ERBB2 and breast carcinoma: Although TUBB3 gene expression appeared to be an independent factor for breast cancer patients with luminal A/B subtypes, a Cox regression analysis of recurrence-free survival probability revealed that TUBB3 was not a useful prognostic factor for patients with HER2-enriched and basal-like (>75% triple-negative) breast cancers [10].